Soiken Holdings Inc.
Research Soiken Holdings Inc. (2385.T) on Bullrun: market cap JPY 5.81B, P/E 27.4, dividend yield 4.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2385.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyJPY
- Market capJPY 5.81B
- P/E27.4
- Dividend yield4.6%
- Financial periodFY2025
Valuation Snapshot
latest market cap is JPY 5.81B; P/E is 27.4; dividend yield is 4.6%.
Peer valuation comparison
Latest P/E is 27.37x versus a Healthcare sector median of 21.69x (26.2% above).
Latest dividend yield is 4.63% versus a Healthcare sector median of 2.41% (92.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | n/a | n/a | n/a | n/a | -8.05 | n/a | n/a | n/a |
| FY2024 | JPY 5.16B | -JPY 662.20M | -JPY 895.42M | 48.1% | -25.32 | JPY 4.79B | n/a | JPY 6.23B |
| FY2023 | JPY 8.08B | JPY 451.85M | -JPY 141.08M | 46.0% | 17.27 | JPY 5.95B | n/a | JPY 6.97B |
| FY2022 | JPY 9.35B | JPY 809.71M | JPY 2.09B | 45.6% | 30.95 | JPY 6.02B | n/a | JPY 6.65B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 5.81B | 27.4 | 4.5% | 10 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 10 JPY, yield 4.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 5 JPY |
| FY2023 | 5 JPY |
| FY2022 | 5 JPY |
About Soiken Holdings Inc.
Soiken Holdings Inc. engages in the development of biomarkers in Japan and internationally. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Soiken Holdings Inc.'s market cap?
Soiken Holdings Inc.'s market capitalization is JPY 5.81B.
What is Soiken Holdings Inc.'s P/E ratio?
Soiken Holdings Inc.'s price-to-earnings (P/E) ratio is 27.4.
Does Soiken Holdings Inc. pay a dividend?
Soiken Holdings Inc. has a dividend yield of 4.6%.
What does Soiken Holdings Inc. do?
Soiken Holdings Inc. engages in the development of biomarkers in Japan and internationally. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives.